Department of Medical Oncology, National Cancer Center/Cancer hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
State Key Laboratory of Molecular Oncology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Sci Rep. 2017 Jul 20;7(1):5995. doi: 10.1038/s41598-017-06327-4.
It is particularly important to provide precise therapies and understand tumor heterogeneity based on the molecular typing of mutational landscape. However, the landscape of somatic mutations in different subtypes of advanced breast cancer (ABC) is largely unknown. We applied target-region capture deep sequencing to determine the frequency and spectrum of common cancer-related gene mutations in circulating tumor DNA (ctDNA) among different ABC subtypes and analyze their association with clinical features. In this retrospective study of 100 female advanced breast cancer patients, 96 (96.0%) had somatic genomic alterations in ctDNA, including copy number variants and point mutations. The results revealed that different subtypes of ABC have distinct features in terms of genetic alterations. Multivariate regression analyses revealed that the number of somatic mutations increased with the line of endocrine therapy and the fractions of trunk mutations was positive associated with the line of target therapy.
基于突变景观的分子分型,为患者提供精准治疗和了解肿瘤异质性尤为重要。然而,不同亚型晚期乳腺癌(ABC)中的体细胞突变景观在很大程度上尚不清楚。我们应用靶向区域捕获深度测序,以确定不同 ABC 亚型循环肿瘤 DNA(ctDNA)中常见癌症相关基因的突变频率和谱,并分析它们与临床特征的关联。在这项对 100 名女性晚期乳腺癌患者的回顾性研究中,96 名(96.0%)患者的 ctDNA 中存在体细胞基因组改变,包括拷贝数变异和点突变。结果表明,不同亚型的 ABC 在遗传改变方面具有不同的特征。多变量回归分析表明,体细胞突变数量随内分泌治疗线数的增加而增加,主干突变分数与靶向治疗线数呈正相关。